The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| INSEEGO CORP | Note 3.250%5/0 | 45782BAD6 | 14,616,153 | 24,456,000 | PRN | DFND | 0 | 0 | 24,456,000 | |||
| INSEEGO CORP | COMMON | 45782B104 | 7,559,226 | 13,033,149 | SH | DFND | 0 | 0 | 1,067,645 | |||
| INSEEGO CORP | COMMON | 45782B104 | 4,416,601 | 7,614,830 | SH | DFND | 1 | 0 | 0 | 7,614,830 | ||
| MIRATI THERAPEUTICS INC | COMMON | 60468T105 | 116,595,216 | 3,135,966 | SH | DFND | 1 | 0 | 0 | 3,135,966 | ||
| Tango Therapeutics Inc. | Common | 87583X109 | 106,496 | 26,961 | SH | DFND | 1 | 0 | 0 | 26,961 | ||